E
Cytek Biosciences, Inc. CTKB
$4.14 -$0.03-0.72% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 46.49% -84.83% 75.23% 114.56% -137.78%
Total Depreciation and Amortization 20.48% 17.24% 13.03% 9.77% 1.43%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -42.36% -7.82% -190.12% 26.10% 44.52%
Change in Net Operating Assets -109.68% 64.00% -43.27% 161.85% 259.15%
Cash from Operations -98.26% -103.16% -79.01% 411.89% 317.68%
Capital Expenditure -49.76% -49.74% 40.40% 23.98% 19.80%
Sale of Property, Plant, and Equipment -69.74% -- -- -- --
Cash Acquisitions -- -- -99.58% -- --
Divestitures -- -- -- -- --
Other Investing Activities -595.47% 297.96% -302.13% -133.33% -26.91%
Cash from Investing -911.72% 264.27% -318.24% -136.66% -27.53%
Total Debt Issued 46,266.67% -50.50% -- -- --
Total Debt Repaid -2.16% -992.09% 0.71% -1.45% 1.42%
Issuance of Common Stock -37.69% -92.29% -32.11% -66.67% -15.04%
Repurchase of Common Stock -64.71% -7,167.57% 79.56% -41.03% -156.41%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -52.07% -815.75% 89.22% -46.05% -892.13%
Foreign Exchange rate Adjustments -140.72% -172.45% 284.45% -163.98% 324.85%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -325.92% -328.06% -1,688.55% -148.67% 1,132.59%